DaVita HealthCare Partners Inc (DVA): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

DaVita HealthCare Partners ( DVA) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole was unchanged today. By the end of trading, DaVita HealthCare Partners rose $1.25 (1.9%) to $66.49 on average volume. Throughout the day, 1,811,864 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 2,088,600 shares. The stock ranged in a price between $65.21-$66.76 after having opened the day at $65.21 as compared to the previous trading day's close of $65.24. Other companies within the Health Services industry that increased today were: Pro-Dex ( PDEX), up 41.7%, Thermogenesis Corporation ( KOOL), up 14.3%, CombiMatrix Corporation ( CBMX), up 10.8% and Alpha Pro Tech ( APT), up 8.6%.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $13.8 billion and is part of the health care sector. The company has a P/E ratio of 24.4, above the S&P 500 P/E ratio of 17.7. Shares are up 3.0% year to date as of the close of trading on Tuesday. Currently there are 9 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, IsoRay ( ISR), down 14.4%, ImmunoCellular Therapeutics ( IMUC), down 9.7%, Concord Medical Services Holdings ( CCM), down 7.8% and Hooper Holmes ( HH), down 6.3% , were all laggards within the health services industry with Hologic ( HOLX) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers